Track the Zura Bio Ltd share price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares are listed on the US market, under the supervision of SEC (Form 4). Market capitalisation: €328.7m. The latest transaction was reported on 2 March 2026 (Acquisition). Among the most active insiders: Howell Michael. All data is free.
21
Insider Decl.
n/a
Thresholds
€15m
7 ops.
Buy Volume
€20m
4 ops.
Sell Volume
41Σ signal
Buys €15m€20m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
2,337,630 sharesClass A ordinary sharesSEC:0001104659-23-035745:0
21 of 21 declarations
About Zura Bio Ltd
Zura Bio Ltd is a biotechnology company focused on developing innovative treatments for autoimmune diseases. It is listed on NASDAQ under the ticker symbol ZURA.